amiea med
amiea med, a brand of Berlin-based MT.DERM GmbH, designs and manufactures FDA-cleared and EU MDR-certified medical microneedling devices (EXCEED) and disposable safety cartridges for dermatologists, plastic surgeons, and licensed skincare therapists globally.
- Company typePrivate
- Founded2011
- HeadquartersBerlin, Germany
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What amiea med does
amiea med is the medical aesthetics brand of MT.DERM GmbH, a family-owned private limited company incorporated in Berlin, Germany (HRB 70730) with copyright dating to 2011. The company designs, develops, and manufactures medical microneedling devices for percutaneous collagen induction (PCI), serving dermatologists, plastic surgeons, aesthetic physicians, and licensed skincare therapists in regulated global markets. The flagship EXCEED device is FDA 510(k)-cleared (K180778 for facial wrinkles; K182407 for facial acne scars) and EU MDR-certified, and is produced in a 5,200 m² ISO 13485-certified cleanroom facility in Berlin with CNC machines and specialized manufacturing automation.
The product platform centers on the EXCEED hardware device (power unit, cable-connected handpiece, footswitch, adjustable needle speed 100-150 Hz, depth 0-1.9 mm) paired with a disposable safety cartridge consumable protected by a patented safety membrane that prevents liquid backflow contamination. The portfolio is rounded out with accessories (device stand, hygiene sleeves) and a cosmetics line (Bare Skin Cleanser, Cell Activator Serum, Skin Repair Moisturiser, Face Relief Mask) designed to enhance and prolong post-treatment outcomes. R&D staff are sourced from the Technical University of Berlin, and the company holds TÜV SÜD certification partner status.
Revenue mechanics combine capital equipment sales (EXCEED device) with a recurring cartridge consumable annuity and accessories/cosmetics uplift. Go-to-market is executed through authorized retailers globally, supplemented by direct consultation inquiries, an Education Hub for practitioner training and certification, clinical-evidence marketing referencing peer-reviewed outcomes (78% periorbital wrinkle reduction in 90 days, 90% facial wrinkle improvement, 86% acne scar improvement), and event partnerships with industry bodies including IMCAS and DGPraec. Public pricing is not disclosed; the company operates contact-based B2B sales with placeholder pricing on its website.
amiea med firmographics
Firmographics- Name
- amiea med
- Legal name
- MT.DERM GmbH
- Website
- https://amieamed.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- amiea med, a brand of Berlin-based MT.DERM GmbH, designs and manufactures FDA-cleared and EU MDR-certified medical microneedling devices (EXCEED) and disposable safety cartridges for dermatologists, plastic surgeons, and licensed skincare therapists globally.
- Ownership category
- akta.pro rank
amiea med industry classification
Industry- Product category
- Medical Aesthetic Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Toilet Preparation Manufacturing (32562)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Microneedling / Collagen Induction Therapy (HSALADAI)
- akta.pro secondary industries
- Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning) (CRABAKAI), Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG)
Keywords
Where amiea med is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
amiea med business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Medical Microneedling Devices: Sale of EXCEED device — a cutting-edge, clinically proven microneedling device sold as a classic device with power unit, cable connected handpiece, and footswitch. Primary capital equipment revenue.
- Safety Cartridges: Disposable hygienic needle cartridges for the EXCEED device. Patented safety membrane prevents contamination. Recurring consumable revenue from repeat purchases by practitioners.
- Accessories: EXCEED device stand (for stability and workflow optimization) and hygiene sleeves (protecting against contamination from bodily fluids). Ancillary product revenue.
- Cosmetics: Skincare product line including Bare Skin Cleanser, Cell Activator Serum, Skin Repair Moisturiser, and Face Relief Mask. Sold as adjunct products to enhance and prolong microneedling treatment results.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | No public pricing available — contact-based sales through authorized retailers |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
amiea med product offering
Product offeringCore offering
amiea med designs, develops, and manufactures the EXCEED medical microneedling device and supporting product line for medical aesthetics professionals. The offering comprises the EXCEED device (power unit, handpiece, footswitch), disposable hygienic safety cartridges with patented membrane, accessories (device stand, hygiene sleeves), and a complementary cosmetics line formulated for post-microneedling skin treatment. All devices are produced in ISO 13485-certified cleanroom facilities in Berlin, Germany.
Product overview
Amiea med is a brand of MT.DERM GmbH that manufactures medical microneedling devices and skincare products. The product portfolio centers on the EXCEED microneedling device (the core platform), supported by disposable safety cartridges and accessories (device stand, hygiene sleeves), and complemented by a cosmetics line (Bare Skin Cleanser, Cell Activator Serum, Skin Repair Moisturiser, Face Relief Mask) designed to enhance microneedling treatments.
Differentiator
Problem solved
Functional benefit
Products and services
- EXCEED Medical Microneedling Device FDA-cleared and MDR-certified medical microneedling device for treating facial acne scars and wrinkles in adult patients. Features adjustable needle speed (100-150 Hz), adjustable needle length (0-1.9 mm), cable-connected handpiece, power unit, and footswitch. Sold to medical aesthetics professionals including dermatologists, plastic surgeons, and aesthetic physicians.
- EXCEED Safety Cartridges Disposable hygienic cartridge system with patented safety membrane that prevents liquid backflow and contamination to the handpiece. Features a 6-point needle plate with 1.5 mm needle length and tilting needle plate for perpendicular skin penetration. Sold as a recurring-use consumable to EXCEED device owners.
- EXCEED Accessories Ancillary products for the EXCEED device including a device stand for stability and workflow convenience, and hygiene sleeves that protect against contamination from bodily fluids during treatment.
- Amiea Med Cosmetics Line Skincare products designed to enhance microneedling treatments, including Bare Skin Cleanser, Cell Activator Serum, Skin Repair Moisturiser, and Face Relief Mask (biocellulose sheet mask). Sold as adjunct products to practitioners and end users to improve absorption of active ingredients and reduce inflammation post-treatment.
Quantifiable outcome
- 78% of patients experienced a remarkable reduction in periorbital wrinkles in just 90 days
- +3 more outcomes
Companies that use amiea med
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
amiea med technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
amiea med partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered minor and core.
- Remy&RemyminorRemy&Remy is credited as the website developer for the amiiea med website. This is a vendor/agency relationship for website design and development services.
- TÜV SÜDcoreTÜV SÜD is shown as a certification partner on the amiiea med website, indicating compliance certification for quality and safety standards in medical device manufacturing.
- DGPraec (Deutsche Gesellschaft für Ästhetische Botulinumtoxin-Therapie)minorDGPraec (German Society for Aesthetic Botulinumtoxin Therapy) is listed as an event partner, with their logo displayed on the events page.
- IMCAS (International Master Course on Aging Science)minorIMCAS is listed as an event partner for IMCAS World 2027, with their logo displayed on the events page. IMCAS is a global educational organization for plastic surgery and dermatology.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
amiea med competitors and assessment
Company assessmentEmerging players
- EndyMed Medical: EndyMed offers Intensif, a microneedling/RF platform targeting acne scars and skin rejuvenation indications overlapping with EXCEED. It is smaller and more regionally focused than InMode or Cutera but directly competes for the same clinical use cases.
Regional players
- Aesthetic Management Partners: Aesthetic Management Partners distributes aesthetic devices including microneedling systems to US practices, comparable in go-to-market motion (authorized-reseller distribution) to amiea med's US strategy. It represents a regional channel-side peer rather than a device-architecture competitor.
Direct peers
- Dermapen World: Dermapen World manufactures Dermapen 4, a leading global microneedling device brand with a strong practitioner following and proprietary needle cartridge system. It competes head-to-head with EXCEED in clinics and med-spas across both the EU and US.
- Eclipse MedCorp (MicroPen Evo): Eclipse's MicroPen Evo is a cordless, automated microneedling device widely used in dermatology and aesthetic practices. It is a direct alternative to EXCEED with similar clinical indications, treatment depth ranges, and cartridge-based recurring revenue.
- Crown Aesthetics (SkinPen): Crown Aesthetics markets SkinPen, the first FDA-cleared microneedling device in the US, directly competing with EXCEED in dermatology and plastic surgery practices. Both target the same clinical indications (acne scars, wrinkles) with a similar razor-and-blade cartridge model and comparable price points.
Broad incumbents
- Candela (Gentle Pro / Vbeam / Matrix): Candela is a global medical aesthetics incumbent offering laser and energy-based devices for skin rejuvenation indications that compete with EXCEED for practice capex budgets. Its broader portfolio and large global sales force make it a broader-scope competitor.
- InMode (Morpheus8): InMode's Morpheus8 is a leading RF-microneedling platform combining fractional radiofrequency with microneedling, competing with EXCEED for the same patient indications and practice budgets. InMode is a broader, publicly listed aesthetics incumbent with significantly larger sales and marketing scale.
- Sinclair Pharma (MaiLi / Perfectha): Sinclair Pharma is an aesthetics company with a portfolio of injectable and skin-quality products overlapping with the patient journey that drives EXCEED demand. While not a direct microneedling competitor, it is a strategic consolidator-type adjacent in the professional aesthetics channel.
- Venus Concept (Venus Viva / Venus Versa): Venus Concept markets microneedling and RF-microneedling solutions aimed at medical aesthetics practices. It competes with EXCEED across rejuvenation and acne-scar use cases and operates a global aesthetics sales infrastructure.
- Cutera (Secret RF / VirtueRF): Cutera markets Secret RF and VirtueRF, RF-microneedling devices that compete with EXCEED on acne scars and rejuvenation indications. As a publicly listed aesthetics platform, Cutera offers broader portfolios and a larger US sales infrastructure than amiea med.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
amiea med social profiles
Digital presenceamiea med compliance and trust
Trust signalCompliance3 records
amiea med financial estimates
Financial estimateRevenue estimate
Valuation estimate
amiea med leadership team
Management profileNumber of profiles
Profiles2 records
amiea med funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
amiea med M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about amiea med
What does amiea med do?
amiea med designs, develops, and manufactures the EXCEED medical microneedling device and supporting product line for medical aesthetics professionals. The offering comprises the EXCEED device (power unit, handpiece, footswitch), disposable hygienic safety cartridges with patented membrane, accessories (device stand, hygiene sleeves), and a complementary cosmetics line formulated for post-microneedling skin treatment. All devices are produced in ISO 13485-certified cleanroom facilities in Berlin, Germany.
Is amiea med a public or private company?
amiea med is a private company. It is classified as family owned and is currently operating.
When was amiea med founded?
amiea med was founded in 2011. It employs 1 to 10 people.
Where is amiea med based?
amiea med is headquartered in Berlin, Germany, in the Europe region.
How does amiea med make money?
Four revenue lines are on record. Medical Microneedling Devices are the primary driver. The others are safety Cartridges, accessories and cosmetics.
Who are amiea med's main competitors?
EndyMed Medical is listed as an emerging player. Aesthetic Management Partners is listed as a regional player. Direct peers are Dermapen World, Eclipse MedCorp (MicroPen Evo) and Crown Aesthetics (SkinPen). Broad incumbents are Candela (Gentle Pro / Vbeam / Matrix), InMode (Morpheus8), Sinclair Pharma (MaiLi / Perfectha), Venus Concept (Venus Viva / Venus Versa) and Cutera (Secret RF / VirtueRF).
Does amiea med have an API?
No public API is recorded for amiea med.
What industry is amiea med in?
amiea med's product category is Medical Aesthetic Devices. Its primary akta.pro industry code is HSALADAI, Microneedling / Collagen Induction Therapy, with a secondary code of CRABAKAI, Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning). Its NAICS code is 339112 and its SIC code is 3841.